z-logo
open-access-imgOpen Access
Scleromyxedema with systemic involvement mimics rheumatic diseases
Author(s) -
Fudman Edward J.,
Golbus Joseph,
Ike Robert W.
Publication year - 1986
Publication title -
arthritis & rheumatism
Language(s) - English
Resource type - Journals
eISSN - 1529-0131
pISSN - 0004-3591
DOI - 10.1002/art.1780290716
Subject(s) - medicine , sclerodactyly , dermatology , systemic disease , myxedema , connective tissue disease , scleroderma (fungus) , dysphagia , pathology , dermis , dermatomyositis , monoclonal gammopathy , disease , immunology , autoimmune disease , monoclonal , surgery , calcinosis , monoclonal antibody , thyroid , inoculation , calcification , antibody
Scleromyxedema is an infiltrative skin disease produced by hyaluronic acid deposition in the dermis. A benign monoclonal gammopathy is usually present. We report 2 patients with scleromyxedema and systemic illnesses. Both patients had muscle weakness, dysphagia, and weight loss in addition to the skin changes. One also had sclerodactyly, telangiectasias, and Raynaud's phenomenon. Scleromyxedema with systemic involvement may mimic rheumatic diseases.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom